Trials / Conditions / Hepatitis Delta Virus
Hepatitis Delta Virus
4 registered clinical trials studyying Hepatitis Delta Virus.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants NCT06740474 | Assembly Biosciences | Phase 1 |
| Unknown | Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chroni NCT05070364 | Eiger BioPharmaceuticals | Phase 3 |
| Completed | Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a NCT03719313 | Eiger BioPharmaceuticals | Phase 3 |
| Active Not Recruiting | Liver Fibrosis in Zambian HIV-HBV Co-infected Patients NCT02344680 | University of Alabama at Birmingham | — |